Background and aims Opioid overdose is a leading cause of death during the immediate
time after release from jail or prison. Most jails in the United States do not provide …

Importance Most prisons and jails in the US discontinue medications for opioid use disorder
(MOUD) upon incarceration and do not initiate MOUD prior to release. Objective To model …

Introduction Among individuals who are released from prison, opioid overdose is a leading
cause of death with a risk more than ten-fold the general population. Although the …

Introduction The overdose epidemic persists as a public health crisis in the United States.
Jails are a critical overdose prevention touchpoint. The risk of overdose postincarceration …

Background As opioid overdoses surge, medications for opioid use disorder (MOUD) remain
underutilized. MOUD is rarely offered in correctional facilities although individuals involved …

Purpose To assess post-release outcomes associated with continuation of methadone
treatment in correctional centers. Methods This case-control study of the post-incarceration …

Background Continuation or initiation of MOUDs during incarceration could improve post-
release outcomes by preventing return to opioid use and reducing risk of overdose. People …

Background Buprenorphine is an effective medication for opioid use disorder (MOUD) when
offered in community-based settings, but evidence is limited for incarcerated populations …

Background Medications for opioid use disorder (OUD) are the most effective treatment for
OUD, but uptake of these life-saving medications has been extremely limited in US prisons …

Background Prior studies have documented limited use of medications to treat opioid use
disorders (OUD) for people incarcerated within state prisons in the United States. Using the …